Skip to content
Question
What will a month cost?
Maker's price
$99/box[1]
Read
5 min
Published
September 2026

Vyleesi Cost: The Brand Autoinjector's Price, Coupon and Coverage

What a box of Vyleesi costs with and without insurance, what a month costs at the label's eight-dose limit, and how that compares with compounded PT-141.

ByDerek MossPricing analystPublished

A 4-dose box of Vyleesi costs $99 without coverage[1]. That is $24.75 a dose. The price was read from the maker’s site in September 2026.

Vyleesi is the brand name for bremelanotide, sold elsewhere as PT-141. Why the compounded version is rarely priced up front is in the PT-141 cost guide.

$99

Vyleesi cash price, 4-dose box

Source: Vyleesi site

$24.75

Per dose, at that price

$198

A month at the label's 8-dose limit

$199

Typical compounded PT-141 month (33 sellers)

That puts the brand $1 below the typical compounded month. That holds even at the label’s monthly maximum. Seller prices were read through September 2026.

How the month is counted

Vyleesi is a single-dose autoinjector of 1.75 mg[2]. It is taken as needed, at least 45 minutes before sex[2]. So a month costs doses used, times the dose price.

The label caps that count. No more than one dose in 24 hours[2]. More than 8 doses a month is not recommended[2]. At the cap, you need 2 boxes, or $198.

Cartons come in 2 or 4 autoinjectors[2]. The $99 offer names the 4-dose box[1].

With commercial insurance

The maker says most commercially insured patients pay $0 for a box[1]. The fine print says “as little as”[1]. Each patient is assessed individually[1].

The help covers copay, coinsurance or deductible[1]. It applies to 2 fills every 30 days[1]. Two 4-dose fills match the label’s 8-dose month.

You must be 18 or older[1]. Enrollment cannot be backdated[1]. The maker may end or change the program at any time[1].

With Medicare or Medicaid

Government-insured patients are not eligible for the copay help[1]. Medicare Part D also excludes drugs used for sexual dysfunction[4]. The exception is a drug used for another approved condition[4].

So the cash offer is the realistic route there. General coverage rules are in the insurance guide.

Who is buying it

Vyleesi is approved for premenopausal women with acquired, generalized HSDD[2]. It is not indicated for postmenopausal women or men[2]. FDA approved it on June 21, 2019[3].

The label adds a stop rule. Stop after 8 weeks without improvement[2]. Budget two months before judging the spend.

How the prescription reaches you

The maker’s pharmacy partner handles the copay and applies the savings[1]. Delivery is free, per the maker[1]. How online prescribing works in general is in how online peptide therapy works.

Who can prescribe it is in PT 141 prescription.

Compounded sellers are ranked by monthly price on the PT-141 price board.

FAQ

3 questions

How much does Vyleesi cost without insurance?

The maker's site offers a 4-dose box at a flat cash price when insurance does not cover Vyleesi. The per-dose and monthly figures on this page are arithmetic on that price and the label's 8-dose monthly limit.

Is there a Vyleesi coupon?

Yes, for commercially insured patients. The maker says most may pay as little as nothing for a box, the help applies to 2 fills every 30 days, and government-insured patients are not eligible.

Is Vyleesi covered by insurance?

Some commercial plans cover it. Medicare Part D excludes drugs used for sexual dysfunction by statute, and the maker's copay help excludes government-funded plans.

Sources

4 cited
  1. [1]Cosette Pharmaceuticals, Inc. (2026). Vyleesi (bremelanotide injection): How to get Vyleesi, with copay terms and conditions vyleesi.com. Source
  2. [2]Cosette Pharmaceuticals, Inc. (2025). VYLEESI (bremelanotide) injection, for subcutaneous use: Prescribing Information DailyMed, U.S. National Library of Medicine. Source
  3. [3]U.S. Food and Drug Administration (2019). NDA 210557 approval letter: Vyleesi (bremelanotide) subcutaneous injection Drugs@FDA. Source
  4. [4]United States Code (2024). 42 U.S.C. 1395w-102(e), Covered part D drug defined Office of the Law Revision Counsel. Source